Greenwich LifeSciences, Inc(NASDAQ:GLSI) 
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other human epidermal growth factor receptor 2/neu-expressing (HER2/neu) cancers. Its lead product candidate is the GP2, an immunotherapy, which ...
Website: http://www.greenwichlifesciences.com
Founded: 2006
CEO: Snehal Patel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 9.01
H 9.40
L 8.29
C 8.83
V 389,160
10EMA 8.83
20EMA 8.83
60EMA 8.83
120EMA 8.83
250EMA 8.83